HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

AM 36

Also Known As:
1-(2-(4-chlorophenyl)-2-hydroxy)ethyl-4-(3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methylpiperazine; 4-((4-(2-(4-chlorophenyl)-2-hydroxyethyl)-1-piperazinyl)methyl)-2,6-bis(2-methyl-2-propanyl)phenol; AM-36; AM36 compound; CNSB 002; CNSB-002; CNSB002
Networked: 14 relevant articles (3 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Callaway, J K: 6 articles (11/2006 - 10/2000)
2. Jarrott, B: 5 articles (11/2006 - 10/2000)
3. Beart, P M: 3 articles (07/2004 - 10/2000)
4. Giardina, S F: 2 articles (07/2004 - 04/2001)
5. Enoksson, Frida: 1 article (12/2012)
6. Groth, Anita: 1 article (12/2012)
7. Hermansson, Ann: 1 article (12/2012)
8. Hultcrantz, Malou: 1 article (12/2012)
9. Stalfors, Joacim: 1 article (12/2012)
10. Stenfeldt, Karin: 1 article (12/2012)

Related Diseases

1. Stroke (Strokes)
2. Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
3. Infarction (Infarctions)
4. Hyperalgesia
5. Ureteral Obstruction

Related Drugs and Biologics

1. Morphine (MS Contin)
2. Neuroprotective Agents
3. Antioxidants
4. Endothelin-1 (Endothelin 1)
5. Connective Tissue Growth Factor
6. Sodium Channel Blockers
7. salicylhydroxamic acid (SHAM)
8. Anaphylatoxin C5a Receptor
9. Potassium Channel Blockers (Blockers, Potassium Channel)
10. Brain-Derived Neurotrophic Factor (BDNF)

Related Therapies and Procedures

1. Therapeutics
2. Aftercare (After-Treatment)
3. Treatment Delay